Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 13, 2023

Effectiveness and Safety of Natalizumab Therapy in Patients With MS in Austria

Journal of Neurology

 

Additional Info

Journal of Neurology
Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
J Neurol 2023 Apr 19;[EPub Ahead of Print], T Monschein, S Dekany, T Zrzavy, M Ponleitner, P Altmann, G Bsteh, B Kornek, P Rommer, C Enzinger, F Di Pauli, J Kraus, T Berger, F Leutmezer, M Guger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading